paclitaxel has been researched along with Diabetic Neuropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, S; Berta, T; Ji, RR; Kim, YH; Oh, SB; Wang, F; Xu, ZZ; Zhang, Y | 1 |
| Beard, SM; Garcia-Cebrian, A; Le, TK; Malik, RA; McCrink, L; Monz, B | 1 |
| Crain, SM | 1 |
| Bartke, I; Reiter, R; Schmidt, Y; Unger, JW | 1 |
| Aghajanian, C; Almadrones, L; Fennelly, D; Gogas, H; Hoskins, WJ; Shapiro, F; Spriggs, DR | 1 |
| Apfel, SC | 1 |
1 review(s) available for paclitaxel and Diabetic Neuropathies
| Article | Year |
|---|---|
Neurotrophic factors and diabetic peripheral neuropathy.
Topics: Animals; Diabetic Neuropathies; Disease Models, Animal; Humans; Nerve Compression Syndromes; Nerve Growth Factors; Paclitaxel; Peripheral Nervous System Diseases; Vinblastine | 1999 |
5 other study(ies) available for paclitaxel and Diabetic Neuropathies
| Article | Year |
|---|---|
Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade.
Topics: Adult; Aged; Anesthetics, Local; Animals; Antineoplastic Agents; Capsaicin; Diabetic Neuropathies; Female; Flagellin; Ganglia, Spinal; Humans; Hyperalgesia; Lidocaine; Male; Mice; Mice, Knockout; Middle Aged; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neuralgia; Neurofilament Proteins; Neurons; Paclitaxel; Peripheral Nerve Injuries; Sensory System Agents; Toll-Like Receptor 5 | 2015 |
Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK.
Topics: Amines; Amitriptyline; Antidepressive Agents; Cost-Benefit Analysis; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Therapy, Combination; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Models, Econometric; Paclitaxel; Pain Measurement; Prospective Studies; Quality-Adjusted Life Years; Sickness Impact Profile; Thiophenes; Treatment Outcome; United Kingdom | 2008 |
Neurotrophic factors in diabetic neuropathy.
Topics: Animals; Cells, Cultured; Diabetic Neuropathies; Ganglia, Spinal; Naloxone; Naltrexone; Nerve Growth Factors; Paclitaxel | 1995 |
Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice.
Topics: Animals; Calcitonin Gene-Related Peptide; Cisplatin; Diabetic Neuropathies; Ganglia, Spinal; Mice; Nerve Growth Factors; Paclitaxel; Substance P | 1995 |
The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer.
Topics: Adult; Aged; Cisplatin; Diabetes Complications; Diabetic Neuropathies; Female; Hearing Loss, Sensorineural; Humans; Hyperglycemia; Kidney; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Sensation | 1996 |